Chouinard Michel 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Nov 10, 2010
Insider Transaction Report
Form 4
Chouinard Michel
COO, Biovail Labs.Int'l SRL
Transactions
- Exercise/Conversion
Restricted Share Units
2010-11-08−51,329→ 0 totalFrom: 2010-11-08Exp: 2014-08-05→ Common Shares, no par value (51,329 underlying) - Exercise/Conversion
Common Shares, no par value
2010-11-08+102,658→ 105,128 total
Footnotes (2)
- [F1]Each Restricted Share Unit ("RSU") represents a contingent right to receive one common share, no par value, of Valeant Pharmaceuticals International, Inc. and is subject to performance based vesting criteria, providing for vesting ranging from zero (0) to two hundred percent (200%).
- [F2]Represents performance based RSUs that accelerated at 200% in connection with the merger between the issuer (formerly known as Biovail Corporation) and Valeant Pharmaceuticals International and vested following the completion of the issuer's blackout period restrictions on November 8, 2010.